Correlation
The correlation between MRVI and SPY is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
MRVI vs. SPY
Compare and contrast key facts about Maravai LifeSciences Holdings, Inc. (MRVI) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRVI or SPY.
Performance
MRVI vs. SPY - Performance Comparison
Loading data...
Key characteristics
MRVI:
-0.91
SPY:
0.70
MRVI:
-1.78
SPY:
1.02
MRVI:
0.77
SPY:
1.15
MRVI:
-0.81
SPY:
0.68
MRVI:
-1.65
SPY:
2.57
MRVI:
47.96%
SPY:
4.93%
MRVI:
82.37%
SPY:
20.42%
MRVI:
-97.16%
SPY:
-55.19%
MRVI:
-96.29%
SPY:
-3.55%
Returns By Period
In the year-to-date period, MRVI achieves a -58.72% return, which is significantly lower than SPY's 0.87% return.
MRVI
-58.72%
10.84%
-60.32%
-74.05%
-58.35%
N/A
N/A
SPY
0.87%
5.54%
-1.56%
13.18%
14.25%
15.81%
12.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRVI vs. SPY — Risk-Adjusted Performance Rank
MRVI
SPY
MRVI vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MRVI vs. SPY - Dividend Comparison
MRVI has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.22%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.22% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
MRVI vs. SPY - Drawdown Comparison
The maximum MRVI drawdown since its inception was -97.16%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for MRVI and SPY.
Loading data...
Volatility
MRVI vs. SPY - Volatility Comparison
Maravai LifeSciences Holdings, Inc. (MRVI) has a higher volatility of 21.20% compared to SPDR S&P 500 ETF (SPY) at 4.86%. This indicates that MRVI's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...